bpV(phen)  ≥95% V basis

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 25mg in glass bottle
溶解性:溶于水(20mg/mL in H2O)
产品描述:基本信息 产品编号: B10634 产品名称: bpV(phen) CAS: 42494-73-5   储存条件 粉末 -20℃ 四年     分子式: KVO5C12H8N2.XH2O 溶于液体     分子量 350.24     化学名:  Potassium bisperoxo(1,10-phenanthroline)oxovanadate (V) hydrate   生物活性 产品描述 一种胰岛素模拟物,是一种有效的蛋白酪氨酸磷酸酶(PTP)和PTEN抑制剂,对PTEN,PTP-β和PTP-1B的IC50为38nM,343nM和920nM。bpV(phen)在体外抑制原生动物寄生虫利什曼原虫的增殖 靶点 IC50: 38nM (PTEN), 343nM (PTP-β) and 920nM (PTP-1B) Parasite Leishmania Apoptosis 体外研究 bpV(phen) (5μM; 24.5 hours; H9c2 cells) treatment causes a further decrease of cell viability in H/R-injured H9c2 cells. bpV(phen) (5μM; 24.5 hours; H9c2 cells) treatment increases the apoptosis of H/R-injured H9c2 cells. bpV(phen) (5μM; 24.5 hours; H9c2 cells) treatment significantly promotes the accumulation of cytoplasmic Cytochrome C in H/R-injured H9c2 cells. After stimulation of bpV(phen), PTEN-induced putative kinase protein 1 (PINK1)/Parkin-mediated mitophagy is inhibited. bpV(phen) is an insulin-mimetic agent following insulin-receptor tyrosine kinase hyperphosphorylation and activation Cell Viability Assay Cell Line: Hypoxia/reoxygenation (H/R)-injured H9c2 cells Concentration: 5μM Incubation Time: 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) Result: Caused a further decrease of cell viability. Apoptosis Analysis Cell Line: Hypoxia/reoxygenation (H/R)-injured H9c2 cells Concentration: 5μM Incubation Time: 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) Result: Increased the apoptosis of H/R-injured H9c2 cells. Western Blot Analysis Cell Line: Hypoxia/reoxygenation (H/R)-injured H9c2 cells Concentration: 5μM Incubation Time: 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) Result: Showed an increased release of Cytochrome C. 体内研究 bpV(phen) (5mg/kg; intraperitoneal injection; daily; for 38 days; male BALB/c nude (nu/nu) athymic mice) treatment causes a significant reduction in average tumor volume Animal Model: Male BALB/c nude (nu/nu) athymic mice (6-7 weeks old) injected with PC-3 cells Dosage: 5mg/kg Administration: Intraperitoneal injection; daily; for 38 days Result: Caused a significant reduction in average tumor volume.
保存条件:-20℃